BlackRock Fund Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $11K | Buy |
87
+15
| +21% | +$1.9K | ﹤0.01% | 3948 |
|
|
2016
Q3 | $11K | Buy |
72
+8
| +13% | +$1.22K | ﹤0.01% | 3955 |
|
|
2016
Q2 | $7K | Sell |
64
-629
| -91% | -$68.8K | ﹤0.01% | 4045 |
|
|
2016
Q1 | $79K | Sell |
693
-44
| -6% | -$5.02K | ﹤0.01% | 3718 |
|
|
2015
Q4 | $139K | Buy |
737
+32
| +5% | +$6.04K | ﹤0.01% | 3648 |
|
|
2015
Q3 | $120K | Sell |
705
-19
| -3% | -$3.23K | ﹤0.01% | 3652 |
|
|
2015
Q2 | $458K | Sell |
724
-6,294
| -90% | -$3.98M | ﹤0.01% | 3241 |
|
|
2015
Q1 | $3.61M | Buy |
7,018
+448
| +7% | +$231K | ﹤0.01% | 2987 |
|
|
2014
Q4 | $3.52M | Buy |
6,570
+915
| +16% | +$490K | ﹤0.01% | 3032 |
|
|
2014
Q3 | $8.48M | Sell |
5,655
-56
| -1% | -$84K | ﹤0.01% | 2452 |
|
|
2014
Q2 | $7.82M | Buy |
5,711
+785
| +16% | +$1.07M | ﹤0.01% | 2573 |
|
|
2014
Q1 | $6.84M | Buy |
4,926
+770
| +19% | +$1.07M | ﹤0.01% | 2625 |
|
|
2013
Q4 | $4.14M | Sell |
4,156
-188
| -4% | -$187K | ﹤0.01% | 2935 |
|
|
2013
Q3 | $4.52M | Buy |
4,344
+503
| +13% | +$524K | ﹤0.01% | 2879 |
|
|
2013
Q2 | $4.18M | Buy |
+3,841
| New | +$4.18M | ﹤0.01% | 2813 |
|